Cargando…

Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection

Recurrent Clostridioides difficile infections (rCDI) have a substantial impact on healthcare systems, with limited and often expensive therapeutic options. Nonalcoholic fatty liver disease (NAFLD) affects about 25% of the adult population and is associated with metabolic syndrome, changes in gut mic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Šamadan, Lara, Jeličić, Mia, Vince, Adriana, Papić, Neven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300633/ https://www.ncbi.nlm.nih.gov/pubmed/34198964 http://dx.doi.org/10.3390/antibiotics10070780

Ejemplares similares

Do Semaphorins Play a Role in Development of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease?
por: Šamadan, Lara, et al.
Publicado: (2022)

Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study
por: Vrsaljko, Nina, et al.
Publicado: (2022)

The Impact of Nonalcoholic Fatty Liver Disease on Severe Community-Acquired Pneumonia Outcomes
por: Gjurašin, Branimir, et al.
Publicado: (2022)

Distinct Cytokine Profiles in Severe COVID-19 and Non-Alcoholic Fatty Liver Disease
por: Papic, Neven, et al.
Publicado: (2022)

1347. Do Class 3 Semaphorins Play a Role in COVID-19 Outcomes in Patients with Non-alcoholic Fatty Liver Disease?
por: Vargovic, Martina, et al.
Publicado: (2023)

2411. One Dose Vancomycin Prophylaxis for In-Hospital Clostridioides difficile - Associated Disease
por: Papic, Neven, et al.
Publicado: (2019)

311. Impact of Non-alcoholic Fatty Liver Disease on Clinical Outcomes in Patients with COVID-19
por: Vrsaljko, Nina, et al.
Publicado: (2021)

Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status
por: Kiseleva, Yana V, et al.
Publicado: (2023)

Association of Immune Semaphorins with COVID-19 Severity and Outcomes
por: Vargovic, Martina, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection
por: Jiang, Yi, et al.
Publicado: (2021)

145. Liver Steatosis as a Risk Factor for Invasive Group B Streptococcus Infection in Non-Pregnant Adults
por: Papic, Neven, et al.
Publicado: (2019)

Unresolved issues in hepatitis C: The role of liver non-parenchymal cells and semaphorins
por: Vince, Adriana, et al.
Publicado: (2018)

Risk Factors Associated with Recurrent Clostridioides difficile Infection
por: Negrut, Nicoleta, et al.
Publicado: (2020)

Clinical and Laboratoy Characteristics of Parvovirus B19 Infection During 2013/2014 Outbreak in Zagreb, Croatia
por: Ajdukovic, Mia, et al.
Publicado: (2017)

Epidemiology of community-acquired and recurrent Clostridioides difficile infection
por: Fu, Yichun, et al.
Publicado: (2021)

400. Rehospitalization of Patients for Recurrent Clostridioides difficile Infection
por: Drwiega, Emily, et al.
Publicado: (2022)

Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis
por: Phatharacharukul, Parkpoom, et al.
Publicado: (2020)

Novel and emerging sources of Clostridioides difficile infection
por: Turner, Nicholas A., et al.
Publicado: (2019)

Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections
por: Granata, Guido, et al.
Publicado: (2021)

Liver involvement during influenza infection: perspective on the 2009 influenza pandemic
por: Papic, Neven, et al.
Publicado: (2011)

Pet Ownership Protects Against Recurrence of Clostridioides difficile Infection
por: Redding, Laurel E, et al.
Publicado: (2020)

Virulence Factors of Clostridioides (Clostridium) difficile Linked to Recurrent Infections
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2019)

Review of the Impact of Biofilm Formation on Recurrent Clostridioides difficile Infection
por: Rubio-Mendoza, Daira, et al.
Publicado: (2023)

Pseudomembranes on colostomy in a patient with recurrent Clostridioides difficile infection
por: Ueda, Hideki, et al.
Publicado: (2023)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Gut metabolites predict Clostridioides difficile recurrence
por: Dawkins, Jennifer J., et al.
Publicado: (2022)

Microbiota in Clostridioides difficile-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
por: Gazzola, Alessandra, et al.
Publicado: (2020)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2023)

Clostridioides difficile Infection: A Room for Multifaceted Interventions
por: Petrosillo, Nicola, et al.
Publicado: (2020)

299. Distinct TGF-β1 Patterns in Patients with Sepsis and Non-alcoholic Fatty Liver Disease
por: Papic, Neven, et al.
Publicado: (2023)

789. Evaluation of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence
por: Johnson, Tanner M, et al.
Publicado: (2020)

Clostridioides difficile Infection in Liver Cirrhosis: A Concise Review
por: Liu, Yuanbin, et al.
Publicado: (2022)

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
por: Kullar, Ravina, et al.
Publicado: (2020)

Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection
por: Normington, Charmaine, et al.
Publicado: (2021)

Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection
por: Escudero-Sánchez, Rosa, et al.
Publicado: (2020)

Health-related quality of life in patients with recurrent Clostridioides difficile infections
por: Hammeken, Lianna H., et al.
Publicado: (2022)

Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Soveral, Lucas F, et al.
Publicado: (2022)

The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection
por: Seekatz, Anna Maria, et al.
Publicado: (2022)

Treatment issues in recurrent Clostridioides difficile infections and the possible role of germinants
por: Budi, Noah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vc3kdjpmrouaq5e2eg2t8ebhf6